Establishment and initial characterization of SOX2-overexpressing NT2/D1 cell clones

Genetics and Molecular Research

Volumn 11, Issue 2, 2012, Pages 1385-1400

  Drakulic, D ^a   Krstic, A ^a   Stevanovic, M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

NANOG; Neural differentiation; NT2 D1; OCT4; Proliferation; SOX2

Indexed keywords

NEUROGENIC DIFFERENTIATION FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

APOPTOSIS; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CELL LYSATE; CELL PROLIFERATION; CELL RENEWAL; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NANOG GENE; OCTAMER TRANSCRIPTION FACTOR 4 GENE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SOX2 GENE; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84930483910     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.May.15.9     Document Type: Article

References (40)

1. Adachi K, Suemori H, Yasuda SY, Nakatsuji N, et al. (2010). Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 15: 455-470.
2. Andrews PW (1984). Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103: 285-293.
3. Bagchi B, Kumar M and Mani S (2006). CMV promotor activity during ES cell differentiation: potential insight into embryonic stem cell differentiation. Cell Biol. Int. 30: 505-513.
4. Baldassarre G, Boccia A, Bruni P, Sandomenico C, et al. (2000). Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Differ. 11: 517-526.
5. Boer B, Kopp J, Mallanna S, Desler M, et al. (2007). Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res. 35: 1773-1786.
6. Boyer LA, Lee TI, Cole MF, Johnstone SE, et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
7. Bylund M, Andersson E, Novitch BG and Muhr J (2003). Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat. Neurosci. 6: 1162-1168.
8. Chambers I, Silva J, Colby D, Nichols J, et al. (2007). Nanog safeguards pluripotency and mediates germline development. Nature 450: 1230-1234.
9. Chen C and Okayama H (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7: 2745-2752.
10. Chen Y, Shi L, Zhang L, Li R, et al. (2008). The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J. Biol. Chem. 283: 17969-17978.
11. Coyle DE, Li J and Baccei M (2011). Regional differentiation of retinoic acid-induced human pluripotent embryonic carcinoma stem cell neurons. PLoS One 6: e16174.
12. Episkopou V (2005). SOX2 functions in adult neural stem cells. Trends Neurosci. 28: 219-221.
13. Ferri AL, Cavallaro M, Braida D, Di Cristofano A, et al. (2004). Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 131: 3805-3819.
14. Glauche I, Herberg M and Roeder I (2010). Nanog variability and pluripotency regulation of embryonic stem cells-insights from a mathematical model analysis. PLoS One 5: e11238.
15. Graham V, Khudyakov J, Ellis P and Pevny L (2003). SOX2 functions to maintain neural progenitor identity. Neuron 39: 749-765.
16. Houldsworth J, Reuter VE, Bosl GJ and Chaganti RS (2001). ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines. Cell Tissue Res. 303: 371-379.
17. Karsunky H, Mende I, Schmidt T and Moroy T (2002). High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells. Oncogene 21: 1571-1579.
18. Kerley-Hamilton JS, Pike AM, Hutchinson JA, Freemantle SJ, et al. (2007). The direct p53 target gene, FLJ11259/DRAM, is a member of a novel family of transmembrane proteins. Biochim. Biophys. Acta 1769: 209-219.
19. Kopp JL, Ormsbee BD, Desler M and Rizzino A (2008). Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26: 903-911.
20. Lang H, Li M, Kilpatrick LA, Zhu J, et al. (2011). Sox2 up-regulation and glial cell proliferation following degeneration of spiral ganglion neurons in the adult mouse inner ear. J. Assoc. Res. Otolaryngol. 12: 151-171.
21. Liew CG, Draper JS, Walsh J, Moore H, et al. (2007). Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1521-1528.
22. Maerz WJ, Baselga J, Reuter VE, Mellado B, et al. (1998). FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas. Oncogene 17: 761-767.
23. Masui S, Nakatake Y, Toyooka Y, Shimosato D, et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9: 625-635.
24. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
25. Miyagi S, Nishimoto M, Saito T, Ninomiya M, et al. (2006). The Sox2 regulatory region 2 functions as a neural stem cell-specific enhancer in the telencephalon. J. Biol. Chem. 281: 13374-13381.
26. Newman MB, Misiuta I, Willing AE, Zigova T, et al. (2005). Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev. 14: 29-43.
27. Niwa H, Yamamura K and Miyazaki J (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199.
28. Otsubo T, Akiyama Y, Yanagihara K and Yuasa Y (2008). SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br. J. Cancer 98: 824-831.
29. Papanayotou C, Mey A, Birot AM, Saka Y, et al. (2008). A mechanism regulating the onset of Sox2 expression in the embryonic neural plate. PLoS Biol. 6: e2.
30. Perrett RM, Turnpenny L, Eckert JJ, O'Shea M, et al. (2008). The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture. Biol. Reprod. 78: 852-858.
31. Przyborski SA, Morton IE, Wood A and Andrews PW (2000). Developmental regulation of neurogenesis in the pluripotent human embryonal carcinoma cell line NTERA-2. Eur. J. Neurosci. 12: 3521-3528.
32. Przyborski SA, Smith S and Wood A (2003). Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Stem Cells 21: 459-471.
33. Rizzino A (2008). Transcription factors that behave as master regulators during mammalian embryogenesis function as molecular rheostats. Biochem. J. 411: e5-e7.
34. Sandhu JK, Sikorska M and Walker PR (2002). Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J. Neurosci. Res. 68: 604-614.
35. Schoenhals M, Kassambara A, De Vos J, Hose D, et al. (2009). Embryonic stem cell markers expression in cancers. Biochem. Biophys. Res Commun. 383: 157-162.
36. Stevanovic M (2003). Modulation of SOX2 and SOX3 gene expression during differentiation of human neuronal precursor cell line NTERA2. Mol. Biol. Rep. 30: 127-132.
37. Stevanovic M, Zuffardi O, Collignon J, Lovell-Badge R, et al. (1994). The cDNA sequence and chromosomal location of the human SOX2 gene. Mamm. Genome 5: 640-642.
38. Tompkins DH, Besnard V, Lange AW, Keiser AR, et al. (2011). Sox2 activates cell proliferation and differentiation in the respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 45: 101-110.
39. Tonge PD and Andrews PW (2010). Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner. Differentiation 80: 20-30.
40. Zhao S, Nichols J, Smith AG and Li M (2004). SoxB transcription factors specify neuroectodermal lineage choice in ES cells. Mol. Cell Neurosci. 27: 332-342.